The new WHO Essential Medicine List adds oseltamivir into the antiviral medicines list,and replaces bisoprolol with atenolol in the cardiovascular medicines list; WHO proposes the next strategy of rational drug use; WHO also suggests that essential medicine applications should provide all relevant published and unpublished data. China should learn from WHO experience, perfect our essential medicine list, and promote the rational use of essential medicines and the evaluation of essential medicine applications.%WHO的最新版基本药物目录在抗病毒药物部分调入了奥赛米韦,在心血管疾病药物部分将阿替洛尔替换为比索洛尔；提出了合理用药的下一步战略；WHO明确指出基本药物的调入申请应包含所有发表和未发表的证据.我国应借鉴WHO的经验,完善我国基本药物目录、基本药物的合理使用及基本药物的调入申请的评价.
展开▼
